Therapeutic compounds
OwnerCharles A. Nicoletteinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode the compounds, and immune effector cells raised in response to the presentation of these compounds. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compounds of the invention.
Claims18
A compound having the structure:
- 2
A compound having the structure:
- 3
A compound having the structure:
- 4
A peptide comprising the amino acid sequence of SEQ ID NO:
- 2 wherein amino acids 774, 775, 776, 777, 778, 779, and 780 are F, L, F, D, P, T, and T respectively.
A peptide comprising the amino acid sequence of SEQ ID NO:
- 2 wherein amino acids 774, 775, 776, 777, 778, 779, and 780 are F, L, Y, Y, G, T, and T respectively.
A peptide comprising the amino acid sequence of SEQ ID NO:
- 2 wherein amino acids 774, 775, 776, 777, 778, 779, and 780 are F, L, F, T, P, T, and I, respectively.
A polynucleotide that encodes an amino acid sequence comprising the amino acid of SEQ ID NO:
- 3.
A polynucleotide that encodes an amino acid comprising the amino acid sequence of SEQ ID NO:
- 5.
A polynucleotide that encodes an amino acid comprising the amino acid sequence of SEQ ID NO:
- 7.
Dependencies are inferred from the claim text.